Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, a study suggests.
Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined turned out to have more dangerous tumours.
The findings, published in the British Journal Of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.
It also casts doubt on the "active surveillance" strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.
Instead, these patients are often closely monitored but left alone until tests suggest their condition has worsened.
More top news
All cuts have consequences, warns Joel Hills, as he examines which assets may be up for sale if George Osborne decides 'everything must go'.
Tests revealed she was suffering from secretory carcinoma - which affects just "one in a million people" diagnosed with the breast cancer.
A terminally ill cancer patient was led down the 'aisle' in bed at hospital after being told she was unlikely to survive weekend,